US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 8.900
  • +0.110+1.25%
Close Apr 24 16:00 ET
  • 8.900
  • 0.0000.00%
Post 16:04 ET
235.78MMarket Cap-6.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nuvectis Pharma (NVCT) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
70.69%31.63M
70.69%31.63M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-Cash and cash equivalents
70.69%31.63M
70.69%31.63M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
Other current assets
1.35%75K
1.35%75K
5.07%145K
17.58%214K
13.60%284K
25.42%74K
25.42%74K
-32.02%138K
-46.63%182K
-66.22%250K
Total current assets
70.41%31.71M
70.41%31.71M
105.62%35.59M
47.60%27.01M
52.93%30.15M
-3.01%18.61M
-3.01%18.61M
-22.26%17.31M
-26.63%18.3M
21.63%19.71M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
70.41%31.71M
70.41%31.71M
105.62%35.59M
47.60%27.01M
52.93%30.15M
-3.01%18.61M
-3.01%18.61M
-22.26%17.31M
-26.63%18.3M
21.63%19.71M
Liabilities
Current liabilities
Payables
151.16%6.27M
151.16%6.27M
188.10%6.51M
173.67%5.05M
87.15%3.29M
-9.85%2.5M
-9.85%2.5M
-35.25%2.26M
-16.17%1.85M
-16.08%1.76M
-accounts payable
151.16%6.27M
151.16%6.27M
184.79%6.44M
169.61%4.98M
70.10%2.99M
-9.85%2.5M
-9.85%2.5M
-35.25%2.26M
2.38%1.85M
-16.08%1.76M
-Other payable
----
----
--75K
--75K
--300K
----
----
----
----
----
Current accrued expenses
-86.31%115K
-86.31%115K
-76.95%65K
-99.35%2K
77.98%865K
102.41%840K
102.41%840K
78.48%282K
-45.71%310K
211.54%486K
Current liabilities
49.49%13.3M
49.49%13.3M
83.30%11.58M
75.65%10.14M
61.52%9.19M
27.35%8.89M
27.35%8.89M
13.27%6.32M
25.19%5.77M
44.69%5.69M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
49.49%13.3M
49.49%13.3M
83.30%11.58M
75.65%10.14M
61.52%9.19M
27.35%8.89M
27.35%8.89M
13.27%6.32M
25.19%5.77M
44.69%5.69M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-36.10%-99.69M
-36.10%-99.69M
-37.88%-92.37M
-35.11%-84.91M
-34.51%-78.58M
-35.03%-73.25M
-35.03%-73.25M
-40.68%-67M
-50.55%-62.84M
-62.11%-58.42M
Paid-in capital
42.36%118.1M
42.36%118.1M
49.23%116.38M
35.04%101.78M
37.40%99.53M
24.85%82.96M
24.85%82.96M
21.27%77.99M
21.42%75.37M
49.95%72.44M
Total stockholders'equity
89.57%18.41M
89.57%18.41M
118.45%24.01M
34.67%16.87M
49.44%20.95M
-20.39%9.71M
-20.39%9.71M
-34.13%10.99M
-38.38%12.53M
14.24%14.02M
Total equity
89.57%18.41M
89.57%18.41M
118.45%24.01M
34.67%16.87M
49.44%20.95M
-20.39%9.71M
-20.39%9.71M
-34.13%10.99M
-38.38%12.53M
14.24%14.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 70.69%31.63M70.69%31.63M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-3.10%18.53M-22.17%17.17M-26.36%18.12M25.83%19.46M
-Cash and cash equivalents 70.69%31.63M70.69%31.63M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-3.10%18.53M-22.17%17.17M-26.36%18.12M25.83%19.46M
Other current assets 1.35%75K1.35%75K5.07%145K17.58%214K13.60%284K25.42%74K25.42%74K-32.02%138K-46.63%182K-66.22%250K
Total current assets 70.41%31.71M70.41%31.71M105.62%35.59M47.60%27.01M52.93%30.15M-3.01%18.61M-3.01%18.61M-22.26%17.31M-26.63%18.3M21.63%19.71M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 70.41%31.71M70.41%31.71M105.62%35.59M47.60%27.01M52.93%30.15M-3.01%18.61M-3.01%18.61M-22.26%17.31M-26.63%18.3M21.63%19.71M
Liabilities
Current liabilities
Payables 151.16%6.27M151.16%6.27M188.10%6.51M173.67%5.05M87.15%3.29M-9.85%2.5M-9.85%2.5M-35.25%2.26M-16.17%1.85M-16.08%1.76M
-accounts payable 151.16%6.27M151.16%6.27M184.79%6.44M169.61%4.98M70.10%2.99M-9.85%2.5M-9.85%2.5M-35.25%2.26M2.38%1.85M-16.08%1.76M
-Other payable ----------75K--75K--300K--------------------
Current accrued expenses -86.31%115K-86.31%115K-76.95%65K-99.35%2K77.98%865K102.41%840K102.41%840K78.48%282K-45.71%310K211.54%486K
Current liabilities 49.49%13.3M49.49%13.3M83.30%11.58M75.65%10.14M61.52%9.19M27.35%8.89M27.35%8.89M13.27%6.32M25.19%5.77M44.69%5.69M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 49.49%13.3M49.49%13.3M83.30%11.58M75.65%10.14M61.52%9.19M27.35%8.89M27.35%8.89M13.27%6.32M25.19%5.77M44.69%5.69M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -36.10%-99.69M-36.10%-99.69M-37.88%-92.37M-35.11%-84.91M-34.51%-78.58M-35.03%-73.25M-35.03%-73.25M-40.68%-67M-50.55%-62.84M-62.11%-58.42M
Paid-in capital 42.36%118.1M42.36%118.1M49.23%116.38M35.04%101.78M37.40%99.53M24.85%82.96M24.85%82.96M21.27%77.99M21.42%75.37M49.95%72.44M
Total stockholders'equity 89.57%18.41M89.57%18.41M118.45%24.01M34.67%16.87M49.44%20.95M-20.39%9.71M-20.39%9.71M-34.13%10.99M-38.38%12.53M14.24%14.02M
Total equity 89.57%18.41M89.57%18.41M118.45%24.01M34.67%16.87M49.44%20.95M-20.39%9.71M-20.39%9.71M-34.13%10.99M-38.38%12.53M14.24%14.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -